Clinical progression of ocular injury following arsenical vesicant lewisite exposure

References

• Lindsay CD, Hambrook JL, Brown RF, et al. Examination of changes in connective tissue macromolecular components of large white pig skin following application of Lewisite vapour. J Appl Toxicol 2004;24:37–46
   PubMed Web of Science ®Google Scholar
• Sahu C, Pakhira S, Sen K, Das AK. A computational study of detoxification of lewisite warfare agents by British anti-lewisite: catalytic effects of water and ammonia on reaction mechanism and kinetics. J Phys Chem A 2013;117:3496–3506
   PubMed Web of Science ®Google Scholar
• Kehe K, Flohe S, Krebs G, et al. Effects of Lewisite on cell membrane integrity and energy metabolism in human keratinocytes and SCL II cells. Toxicology 2001;163:137–144
   PubMed Web of Science ®Google Scholar
• King JR, Riviere JE, Monteiro-Riviere NA. Characterization of lewisite toxicity in isolated perfused skin. Toxicol Appl Pharmacol 1992;116:189–201
   PubMed Web of Science ®Google Scholar
• Nelson P, Hancock JR, Sawyer TW. Therapeutic effects of hypothermia on lewisite toxicity. Toxicology 2006;222:8–16
   PubMed Web of Science ®Google Scholar
• Nguon N, Clery-Barraud C, Vallet V, et al. Time course of lewisite-induced skin lesions and inflammatory response in the SKH-1 hairless mouse model. Wound Repair Regen 2014;22:272–280
   PubMed Web of Science ®Google Scholar
• Sawyer TW, Nelson P. Hypothermia as an adjunct therapy to vesicant-induced skin injury. Eplasty 2008;8:e25
   PubMedGoogle Scholar
• Beebe GW. Lung cancer in World War I veterans: possible relation to mustard-gas injury and 1918 influenza epidemic. J Natl Cancer Inst 1960;25:1231–1252
   PubMed Web of Science ®Google Scholar
• Javadi MA, Yazdani S, Kanavi MR, et al. Long-term outcomes of penetrating keratoplasty in chronic and delayed mustard gas keratitis. Cornea 2007;26:1074–1078
   PubMed Web of Science ®Google Scholar
• Milhorn D, Hamilton T, Nelson M, McNutt P. Progression of ocular sulfur mustard injury: development of a model system. Ann NY Acad Sci 2010;1194:72–80
   PubMed Web of Science ®Google Scholar
• Banin E, Morad Y, Berenshtein E, et al. Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard. Invest Ophthalmol Vis Sci 2003;44:2966–2972
   PubMed Web of Science ®Google Scholar
• Ghasemi H, Owlia P, Jalali-Nadoushan MR, et al. A clinicopathological approach to sulfur mustard-induced organ complications: a major review. Cutan Ocul Toxicol 2013;32:304–324
   PubMed Web of Science ®Google Scholar
• Olajos EJ, Olson CT, Salem H, et al. Evaluation of neutralized chemical agent identification sets (CAIS) for skin injury with an overview of the vesicant potential of agent degradation products. J Appl Toxicol 1998;18:409–420
   PubMed Web of Science ®Google Scholar
• Watson AP, Griffin GD. Toxicity of vesicant agents scheduled for destruction by the Chemical Stockpile Disposal Program. Environ Health Perspect 1992;98:259–280
   PubMed Web of Science ®Google Scholar
• Mann I, Pirie A, Pullinger BD. A study of lewisite lesions of the eyes of rabbits. Am J Ophthalmol 1946;29:1215–1227
   PubMed Web of Science ®Google Scholar
• Hughes WF Jr. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of lewisite burns of the eye with BAL. J Clin Invest 1946;25:541–548
   PubMed Web of Science ®Google Scholar
• Hughes WF Jr. Treatment of lewisite burns of the eye with dimercaprol (BAL). Arch Ophthal 1947;37:25–41
   PubMedGoogle Scholar
• Mann I, Pirie A, Pullinger BD. The treatment of lewisite and other arsenical vesicant lesions of the eyes of rabbits with British anti-lewisite (BAL). Am J Ophthalmol 1947;30:421–435
   PubMed Web of Science ®Google Scholar
• Mouret S, Wartelle J, Emorine S, et al. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice. Toxicol Appl Pharmacol 2013;272:291–298
   PubMed Web of Science ®Google Scholar
• Boyd VL, Harbell JW, O’Connor RJ, McGown EL. 23-Dithioerythritol, a possible new arsenic antidote. Chem Res Toxicol 1989;2:301–306
   PubMed Web of Science ®Google Scholar
• Amir A, Turetz J, Chapman S, et al. Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits. J Appl Toxicol 2000;20:S109–S114
   PubMedGoogle Scholar
• Gordon MK, Desantis A, Deshmukh M, et al. Doxycycline hydrogels as a potential therapy for ocular vesicant injury. J Ocul Pharmacol Ther 2010;26:407–419
   PubMed Web of Science ®Google Scholar
• Kadar T, Dachir S, Cohen L, et al. Ocular injuries following sulfur mustard exposure-pathological mechanism and potential therapy. Toxicology 2009;263:59–69
   PubMed Web of Science ®Google Scholar
• McNutt P, Hamilton T, Nelson M, et al. Pathogenesis of acute and delayed corneal lesions after ocular exposure to sulfur mustard vapor. Cornea 2012;31:280–290
   PubMed Web of Science ®Google Scholar
• McNutt P, Tuznik K, Nelson M, et al. Structural, morphological, and functional correlates of corneal endothelial toxicity following corneal exposure to sulfur mustard vapor. Invest Ophthalmol Vis Sci 2013;54:6735–6744
   PubMed Web of Science ®Google Scholar
• Kadar T, Turetz J, Fishbine E, et al. Characterization of acute and delayed ocular lesions induced by sulfur mustard in rabbits. Curr Eye Res 2001;22:42–53
   PubMed Web of Science ®Google Scholar
• Kadar T, Dachir S, Cohen M, et al. Prolonged impairment of corneal innervation after exposure to sulfur mustard and its relation to the development of delayed limbal stem cell deficiency. Cornea 2013;32:e44–e50
   Web of Science ®Google Scholar
• Platteborze PL. The transcriptional effects of the vesicants lewisite and sulfur mustard on human epidermal keratinocytes. Toxicol Mech Methods 2005;15:185–192
   PubMed Web of Science ®Google Scholar